An interventional study of Compression continuous suture with suture crimping and Conventional Suture with suture crimping in Primary Pterygium, sponsored by Tianjin Eye Hospital. Recruiting at 1 site in China. Open to participants aged 30 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Tianjin Eye Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Pterygium with a site in China — 2 open to participants now, 4 under way, 1 of them phase 3. Pterygium · China.
Among the 23 studies in Pterygium with a site in China, this one is the 16th largest by planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2024, is one of 13 with no phase, and was the 22nd registered.
109 studies on the registry are indexed under Pterygium; 9 are open to participants now.
Browse Pterygium studies →2 of the 23 studies in Pterygium with a site in China are open now. Recruiting first, the newest first:
Zhongshan Ophthalmic Center, Sun Yat-sen University · Sites in China
Ages 18+ · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 3 Pterygium studies recruiting now, 2 set no upper age limit and 1 stops at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: 30 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 60 across 93 interventional studies indexed under Pterygium.
Median enrollment 60 across the 20 interventional studies, 615 across the 3 observational. Of the 8 that completed or were terminated, 1 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 23 have an industry lead sponsor. The 10 most frequent:
Tianjin Eye Hospital is the lead sponsor of 53 studies on the registry; 18 are open to participants now.
Tianjin Eye Hospital has 1 study filed under Pterygium — fewer than ten, so there is no comparison to draw.
1 of the studies in Pterygium with a site in China that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05456425Phase 3Cloudbreak Therapeutics, LLCA Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies in Pterygium with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To compare the advantages and disadvantages of continuous suture with suture and conventional Suture in primary pterygium surgery for autologous conjunctival graft fixation
Pterygium is an abnormal fibrovascular tissue hyperplasia disease that occurs in the conjunctiva. The pterygium tissue can break through the limbus of the corneosclera and grow into the cornea, causing a foreign body sensation in the eyes, astigmatism, decreased vision, and even restricted eye movement. The purpose of surgical treatment for pterygium is not only to remove the diseased tissue, but more importantly, to reduce the recurrence of pterygium after surgery. Pterygium excision combined with simple autologous conjunctival transplantation is currently the most commonly used method for treating pterygium. The recurrence rate after autologous conjunctival epithelial tissue transplantation can be reduced to 5% to 30%.
As heterogenic substances, sutures can irritate the ocular surface, aggravate postoperative inflammatory reactions and conjunctival edema or hemorrhage, delay the repair of corneal wound epithelium, lead to abnormal ocular surface function, intensify postoperative discomfort, and induce hypertrophic granuloma or cysts, etc. Moreover, these adverse reactions can also induce the recurrence of pterygium (0-26%). In addition, the longer the time interval between suture removal, The greater the difficulty of removal, the more likely some of the knots may be completely buried under the conjunctiva. Therefore, in order to alleviate the adverse reactions caused by sutures and further simplify the operation of pterygium excision surgery, many attempts have been made at home and abroad to improve and innovate the method of graft fixation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pterygium excision combined with autologous conjunctival transplantation was performed
Procedure: Compression continuous suture with suture crimping
Pterygium excision combined with autologous conjunctival transplantation was performed
Procedure: Conventional Suture with suture crimping
Pterygium excision combined with autologous conjunctival transplantation was performed, and the continuous suture method with pressure lines was adopted during the operation
Pterygium excision combined with autologous conjunctival transplantation was performed, and the traditional suture method was adopted during the operation
Duration of surgery
The date on which the surgery was performed
Time frame: Intraoperative
Implant stability
Whether the conjunctival graft is loose or detached
Time frame: Postoperative follow-up was performed 1 day and 1 week after surgery
Postoperative discomfort
The degree of discomfort after surgery was evaluated using the VAS Pain score Scale
Time frame: Postoperative follow-up was performed 1 day and 1 week after surgery
Stitch removal time
The date when the stitches were removed
Time frame: Postoperative follow-up was performed 1 week after surgery
Started Apr 2024 (actual). Primary completion is estimated for Apr 2026, 24 months after the start.
Of 18 interventional studies with no phase under Pterygium, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 28. This study's planned 24 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tianjin Eye Hospital